Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Follow-Up

JL Jakob Liermann
JW Julia K. Winkler
MS Mustafa Syed
UN Ulf Neuberger
DR David Reuss
SH Semi Harrabi
PN Patrick Naumann
JR Jonas Ristau
FW Fabian Weykamp
RS Rami A. El Shafie
LK Laila König
JD Jürgen Debus
JH Jessica Hassel
SR Stefan Rieken
request Request a Protocol
ask Ask a question
Favorite

Follow-up time was defined from the day of SRS until last clinical evaluation or MRI scan. Follow-up was performed at least every 3 months by contrast-enhanced MRI scans and clinical evaluation. For response evaluation, we decided to define local tumor progression through interdisciplinary decision of dermatologists, neuroradiologists and radiation oncologists, whenever the clinical diagnoses seemed reliable. Nevertheless, in some cases there were still doubts about the differentiation between CRN or local tumor progression. In the present study, these uncertain cases were evaluated separately as described in the following paragraph.

Copyright and License information:  ©2020 Liermann, Winkler, Syed, Neuberger, Reuss, Harrabi, Naumann, Ristau, Weykamp, El Shafie, König, Debus, Hassel and Rieken.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A